Search details
1.
Associations between diagnostic time intervals and health-related quality of life, clinical anxiety and depression in adolescents and young adults with cancer: cross-sectional analysis of the BRIGHTLIGHT cohort.
Br J Cancer
; 126(12): 1725-1734, 2022 06.
Article
in English
| MEDLINE | ID: mdl-35190694
2.
Reporting the whole story: Analysis of the 'out-of-scope' questions from the James Lind Alliance Teenage and Young Adult Cancer Priority Setting Partnership Survey.
Health Expect
; 24(5): 1593-1606, 2021 10.
Article
in English
| MEDLINE | ID: mdl-34247435
3.
The support and information needs of adolescents and young adults with cancer when active treatment ends.
BMC Cancer
; 20(1): 697, 2020 Jul 28.
Article
in English
| MEDLINE | ID: mdl-32723357
4.
Development of a patient-reported experience questionnaire for patients with sarcoma: the Sarcoma Assessment Measure (SAM).
Qual Life Res
; 29(8): 2287-2297, 2020 Aug.
Article
in English
| MEDLINE | ID: mdl-32227293
5.
Enhancing accrual to clinical trials of adolescents and young adults with cancer.
Pediatr Blood Cancer
; 65(9): e27233, 2018 09.
Article
in English
| MEDLINE | ID: mdl-29749691
6.
Issues experienced and support provided to adolescents and young adults at the end of active treatment for cancer: A rapid review of the literature.
Eur J Cancer Care (Engl)
; 27(6): e12972, 2018 Nov.
Article
in English
| MEDLINE | ID: mdl-30485604
7.
Novel participatory methods of involving patients in research: naming and branding a longitudinal cohort study, BRIGHTLIGHT.
BMC Med Res Methodol
; 15: 20, 2015 Mar 14.
Article
in English
| MEDLINE | ID: mdl-25888163
8.
Development and validation of the BRIGHTLIGHT Survey, a patient-reported experience measure for young people with cancer.
Health Qual Life Outcomes
; 13: 107, 2015 Jul 28.
Article
in English
| MEDLINE | ID: mdl-26216214
9.
Available, accessible, aware, appropriate, and acceptable: a strategy to improve participation of teenagers and young adults in cancer trials.
Lancet Oncol
; 15(8): e341-50, 2014 Jul.
Article
in English
| MEDLINE | ID: mdl-24988937
10.
The Impact of Specialist Care on Teenage and Young Adult Patient-Reported Outcomes in England: A BRIGHTLIGHT Study.
J Adolesc Young Adult Oncol
; 2024 Jan 30.
Article
in English
| MEDLINE | ID: mdl-38285524
11.
The Sarcoma Assessment Measure (SAM): Preliminary Psychometric Validation of a Novel Patient-Reported Outcome Measure.
Cancers (Basel)
; 16(6)2024 Mar 08.
Article
in English
| MEDLINE | ID: mdl-38539431
12.
Transitioning adolescent and young adult cancer care research out of its adolescence.
Eur J Cancer Care (Engl)
; 27(6): e12962, 2018 Nov.
Article
in English
| MEDLINE | ID: mdl-30485602
13.
Evaluation of the impact of redeployment during the COVID-19 pandemic: results from a multi-centre survey.
J Res Nurs
; 28(6-7): 401-415, 2023 Nov.
Article
in English
| MEDLINE | ID: mdl-38144964
14.
Young people's opinions of cancer care in England: the BRIGHTLIGHT cohort.
BMJ Open
; 13(9): e069910, 2023 09 20.
Article
in English
| MEDLINE | ID: mdl-37730384
15.
Impact of leadership on the nursing workforce during the COVID-19 pandemic.
BMJ Lead
; 7(1): 21-27, 2023 03.
Article
in English
| MEDLINE | ID: mdl-37013871
16.
A Scoping Review Exploring Access to Survivorship Care for Childhood, Adolescent, and Young Adult Cancer Survivors: How Can We Optimize Care Pathways?
Adolesc Health Med Ther
; 14: 153-174, 2023.
Article
in English
| MEDLINE | ID: mdl-37753163
17.
Patient and public involvement to inform priorities and practice for research using existing healthcare data for children's and young people's cancers.
Res Involv Engagem
; 9(1): 71, 2023 Aug 29.
Article
in English
| MEDLINE | ID: mdl-37644582
18.
Fear of Cancer Recurrence in Patients with Sarcoma in the United Kingdom.
Cancers (Basel)
; 15(3)2023 Feb 02.
Article
in English
| MEDLINE | ID: mdl-36765920
19.
Patients' Experiences of a Sarcoma Diagnosis: A Process Mapping Exercise of Diagnostic Pathways.
Cancers (Basel)
; 15(15)2023 Aug 03.
Article
in English
| MEDLINE | ID: mdl-37568761
20.
A Qualitative Study of the Factors Influencing Patients' Experience of Soft Tissue Sarcoma in the United Kingdom.
Clin Neuropharmacol
; 2022 Sep 22.
Article
in English
| MEDLINE | ID: mdl-36480349